The first patients have been included in the HemoCue test at the Oncology Department at Sjælland University Hospital in Næstved. The blood test ing apparatus will be tested in the patient's home.
The Ethical Committees and The Federal Institute for Drugs and Medical Devices (BfArM) in Germany have approved the start-up of trials of Cortrium's C3 device at the University Medical Centre in Schleswig-Holstein.
Last week the Department of Oncology at the University of Southern Denmark, Næstved had cause for celebration. The testing of the measuring unit called the ‘C3’ had been completed. The goal is to improve the treatment for cancer patients.
Dansk
Deutsch
English
